Guidance

MenB risk groups: patient group direction template

Patient group direction (PGD) template to support the provision of MenB vaccine to individuals with underlying medical conditions.

Documents

MenB risk groups: PGD template

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This PGD template supports the provision of additional meningococcal group B vaccine to individuals with underlying medical conditions from 2 years of age.

It is valid from 1 March 2017 to 28 February 2019.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012).

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 1 March 2017
Last updated 1 September 2017 + show all updates
  1. Corrected expiry details in the footer.
  2. First published.